Merck KGaA
MKGAF
$129.45
-$4.45-3.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.85B | 23.51B | 23.09B | 22.88B | 22.88B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.85B | 23.51B | 23.09B | 22.88B | 22.88B |
| Cost of Revenue | 9.80B | 9.66B | 9.54B | 9.29B | 9.33B |
| Gross Profit | 14.04B | 13.85B | 13.55B | 13.59B | 13.55B |
| SG&A Expenses | 6.71B | 6.52B | 6.36B | 6.28B | 6.28B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 55.76M | -163.19M | 110.69M | 308.10M | 266.49M |
| Total Operating Expenses | 19.27B | 18.53B | 18.33B | 18.28B | 18.33B |
| Operating Income | 4.58B | 4.98B | 4.76B | 4.60B | 4.55B |
| Income Before Tax | 3.73B | 4.12B | 3.96B | 3.86B | 3.83B |
| Income Tax Expenses | 779.57M | 839.17M | 830.08M | 826.34M | 814.05M |
| Earnings from Continuing Operations | 2.95K | 3.28K | 3.13K | 3.03K | 3.02K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.71M | -5.08M | -13.06M | -7.50M | -9.77M |
| Net Income | 2.94B | 3.28B | 3.11B | 3.03B | 3.01B |
| EBIT | 4.58B | 4.98B | 4.76B | 4.60B | 4.55B |
| EBITDA | 6.55B | 6.63B | 6.36B | 6.19B | 6.14B |
| EPS Basic | 6.76 | 7.54 | 7.16 | 6.97 | 6.92 |
| Normalized Basic EPS | 6.51 | 6.93 | 6.67 | 6.55 | 6.50 |
| EPS Diluted | 6.76 | 7.54 | 7.16 | 6.97 | 6.92 |
| Normalized Diluted EPS | 6.51 | 6.93 | 6.67 | 6.55 | 6.50 |
| Average Basic Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Average Diluted Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Dividend Per Share | 2.56 | 2.35 | 2.35 | 2.35 | 2.35 |
| Payout Ratio | 39.99% | 35.85% | 37.75% | 36.37% | 36.88% |